BLCM Price Targets and Analyst Ratings NASDAQ:BLCM
BLCM Forecast. What You Should Know.
BLCM Historical Ratings and Targets
About Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.